Stifel Reiterates Buy Rating on Krystal Biotech (KRYS)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. MA
10. FND

Go back to Stifel Reiterates Buy Rating on Krystal Biotech (KRYS)

Krystal Biotech's (KRYS) Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301

August 28, 2024 7:01 AM EDT

Jeune Aesthetics, Inc. (Jeune), a wholly owned subsidiary of Krystal Biotech, Inc. (Krystal) (NASDAQ: KRYS) leveraging Krystals clinically validated gene-delivery platform to fundamentally address and reverse the biology of aging skin, announced today positive interim safety and efficacy results from both Cohorts 3 and 4 of PEARL-1, a Phase 1 study evaluating KB301, an investigational aesthetic treatment designed to deliver the COL3A1 transgene and increase type III... More